In an article recently published on The Register, a diabetic researcher reveals that he identified a vulnerability in the software used to control the flow of life-saving insulin pumps, which would allow a hacker to gain wireless access and increase, decrease or stop the flow of insulin.  He had contacted the company producing the pump - Medtronic - numerous times to report the vulnerability, and was ignored.